News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
Pfizer (NYSE: PFE) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular...
PTC Therapeutics Announces Validation of Sepiapterin European MAA PR Newswire - Review of European marketing application for PKU now initiated - WARREN, N.J. , May 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the sep...
2024-05-20 20:15:01 ET Citigroup analyst issues SELL recommendation for PTCT on May 20, 2024 07:00PM ET. The previous analyst recommendation was Sell. PTCT was trading at $40.12 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current ana...